A Marc
Overview
Explore the profile of A Marc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina N, et al.
Res Sq
. 2021 Feb;
PMID: 33619476
One year into the Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), effective treatments are still needed . Monoclonal antibodies, given alone or as...
2.
Herzberg G, Marc A, Burnier M
Hand Surg Rehabil
. 2016 Nov;
35S:S95-S98.
PMID: 27890220
About 10 years after volar locking plates were introduced to treat acute distal radius fractures, several papers have reported short-term complications. The aim of this paper was to report our...
3.
Sedeaud A, Vidalin H, Tafflet M, Marc A, Toussaint J
J Sports Med Phys Fitness
. 2013 Apr;
53(2):185-91.
PMID: 23584326
Aim: The aim of this paper was to investigate the changes over time in anthropometric parameters of young and adult rugby players in France. Methods: Age, mass and height were...
4.
Wagner A, Marc A, Engasser J, Einsele A
Cytotechnology
. 2012 Feb;
7(1):7-13.
PMID: 22359153
The culture kinetics of human tumor kidney cells (TCL 598) grown on microcarriers are compared with media initially supplemented with either glucose alone or a mixture of galactose and glucose....
5.
Monaco L, Marc A, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, et al.
Cytotechnology
. 2012 Feb;
22(1-3):197-203.
PMID: 22358930
The CHO cell line has achieved considerable commercial importance as a vehicle for the production of human therapeutic proteins, but is known to lack a functional copy of the gene...
6.
Geaugey V, Duval D, Geahel I, Marc A, Engasser J
Cytotechnology
. 2012 Feb;
2(2):119-29.
PMID: 22358624
It is generally accepted that the phase of cell decline observed in batch culture of mammalian cells is related to exhaustion of medium nutrients (principally glucose and glutamine) and/or to...
7.
Cherlet M, Marc A
Cytotechnology
. 2008 Nov;
29(1):71-84.
PMID: 19003339
In this paper, we propose an alternative strategy to the ones proposed before (Oh et al., 1993; Øyaas et al., 1994a) to get real increases of global final antibody titer...
8.
Lamotte D, Buckberry L, Monaco L, Soria M, Jenkins N, Engasser J, et al.
Cytotechnology
. 2008 Nov;
29(1):55-64.
PMID: 19003337
A non-human like glycosylation pattern in human recombinant glycoproteins expressed by animal cells may compromise their use as therapeutic drugs. In order to correct the CHO glycosylation machinery, a CHO...
9.
Quesney S, Marvel J, Marc A, Gerdil C, Meignier B
Cytotechnology
. 2008 Nov;
35(2):115-25.
PMID: 19003288
The density of viable cells in a culture results from a balance between cell proliferation and cell death. The aim of this study was to characterize and compare these two...
10.
Cherlet M, Marc A
Cytotechnology
. 2008 Nov;
32(1):17-29.
PMID: 19002964
Experiments, earlier performed in our laboratory, showedthe stimulating effect of butyric acid on monoclonalantibody production by hybridoma cells. Itssimulaneous inhibitory effect on cell growth canhowever compensate for this, so that...